Bala Venkatesh's Publications

Granholm A, Munch MW, Andersen-Ranberg N et alii
Heterogeneous treatment effects of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia—Post hoc exploratory analyses of the COVID STEROID 2 trial
Journal articles
2023
Acta Anaesthesiologica Scandinavica
Denholm JT, Venkatesh B, Davis J et alii
ASCOT ADAPT study of COVID-19 therapeutics in hospitalised patients: an international multicentre adaptive platform trial
Journal articles
2022
Trials
Ramanan M, Kumar A, Billot L et alii
Recruitment characteristics of randomised trials in critical care: A systematic review
Journal articles
2022
Clinical Trials
Hammond NE, Myburgh J, Seppelt I et alii
Association between Selective Decontamination of the Digestive Tract and In-Hospital Mortality in Intensive Care Unit Patients Receiving Mechanical Ventilation: A Systematic Review and Meta-analysis
Journal articles
2022
JAMA
Hernández-Mitre MP, Tong SYC, Denholm JT et alii
Nafamostat Mesylate for Treatment of COVID-19 in Hospitalised Patients: A Structured, Narrative Review
Journal articles
2022
Clinical Pharmacokinetics
Maslove DM, Tang B, Shankar-Hari M et alii
Redefining critical illness
Journal articles
2022
Nature Medicine
Tirupakuzhi Vijayaraghavan BK, Jha V, Rajbhandari D et alii
Hydroxychloroquine plus personal protective equipment versus personal protective equipment alone for the prevention of laboratory-confirmed COVID-19 infections among healthcare workers: a multicentre, parallel-group randomised controlled trial from India
Journal articles
2022
BMJ Open
Hammond NE, Kumar A, Kaur P et alii
Estimates of Sepsis Prevalence and Outcomes in Adult Patients in the ICU in India: A Cross-sectional Study
Journal articles
2022
Chest
Granholm A, Kjær MBN, Munch MW et alii
Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia
Journal articles
2022
Intensive Care Medicine
Thompson KJ, Young PJ, Venkatesh B et alii
Long-term costs and cost-effectiveness of adjunctive corticosteroids for patients with septic shock in New Zealand
Journal articles
2022
Australian Critical Care
Donaldson LH, Hammond NE, Agarwal S et alii
Outcomes following severe septic shock in a cohort of Aboriginal and Torres Strait Islander people: a nested cohort study from the ADRENAL trial
Journal articles
2022
Critical Care and Resuscitation
Bassi A, Arfin S, Joshi R et alii
Challenges in operationalising clinical trials in India during the COVID-19 pandemic
Journal articles
2022
The Lancet Global Health
Nasa P, Azoulay E, Chakrabarti A et alii
Infection control in the intensive care unit: expert consensus statements for SARS-CoV-2 using a Delphi method
Journal articles
2022
The Lancet Infectious Diseases
Ramanan M, Tong SYC, Kumar A et alii
Geographical Representation of Low-and Middle-Income Countries in Randomized Clinical Trials for COVID-19
Journal articles
2022
JAMA Network Open
Hammond NE, Zampieri FG, Di Tanna GL et alii
Balanced Crystalloids versus Saline in Critically Ill Adults — A Systematic Review with Meta-Analysis
Journal articles
2022
NEJM Evidence
Finfer S, Venkatesh B, Hotchkiss RS et alii
Lymphopenia in sepsis—an acquired immunodeficiency?
Journal articles
2022
Immunology and Cell Biology
Venkatesh B, Schlapbach L, Mason D et alii
Impact of 1-hour and 3-hour sepsis time bundles on patient outcomes and antimicrobial use: A before and after cohort study
Journal articles
2022
The Lancet Regional Health - Western Pacific
Granholm A, Munch MW, Myatra SN et alii
Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial
Journal articles
2022
Intensive Care Medicine
Tirupakuzhi Vijayaraghavan BK, Granholm A, Myatra S et alii
Heterogeneity of treatment effect of higher dose dexamethasone by geographic region in patients with COVID-19 and severe hypoxemia - Apost hocevaluation of the COVID STEROID 2 trial
Preprints
2022
http://dx.doi.org/10.1101/2022.11.23.22282463
Anstey CM, Venkatesh B
A Comparison of the Commonly Used Surrogate Markers for Citrate Accumulation and Toxicity during Continuous Renal Replacement Therapy with Regional Citrate Anticoagulation.
Journal articles
2022
Blood Purif
Hammond N, Myburgh J, Di Tanna GL et alii
Selective Decontamination of the Digestive Tract in Invasively Ventilated Patients in an Intensive Care Unit: A protocol for a Systematic Review and Meta-Analysis
Preprints
2022
http://dx.doi.org/10.1101/2022.03.18.22272586
Denholm J, Venkatesh B, Davis J et alii
ASCOT ADAPT study of COVID-19 therapeutics in hospitalised patients: an international multicentre adaptive platform trial
Preprints
2022
http://dx.doi.org/10.21203/rs.3.rs-1045085/v1
Axfors C, Janiaud P, Schmitt AM et alii
Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials
Journal articles
2021
BMC Infectious Diseases
Munch MW, Myatra SN, Vijayaraghavan BKT et alii
Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive without Life Support in Adults with COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial
Journal articles
2021
JAMA - Journal of the American Medical Association
Ramanan M, Attokaran A, Murray L et alii
Sodium chloride or Plasmalyte-148 evaluation in severe diabetic ketoacidosis (SCOPE-DKA): a cluster, crossover, randomized, controlled trial
Journal articles
2021
Intensive Care Medicine
Munch MW, Meyhoff TS, Helleberg M et alii
Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia: The COVID STEROID randomised, placebo-controlled trial
Journal articles
2021
Acta Anaesthesiologica Scandinavica

Bala Venkatesh's Publications

Heterogeneous treatment effects of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia—Post hoc exploratory analyses of the COVID STEROID 2 trial

ASCOT ADAPT study of COVID-19 therapeutics in hospitalised patients: an international multicentre adaptive platform trial

Recruitment characteristics of randomised trials in critical care: A systematic review

Association between Selective Decontamination of the Digestive Tract and In-Hospital Mortality in Intensive Care Unit Patients Receiving Mechanical Ventilation: A Systematic Review and Meta-analysis

Nafamostat Mesylate for Treatment of COVID-19 in Hospitalised Patients: A Structured, Narrative Review

Redefining critical illness

Hydroxychloroquine plus personal protective equipment versus personal protective equipment alone for the prevention of laboratory-confirmed COVID-19 infections among healthcare workers: a multicentre, parallel-group randomised controlled trial from India

Estimates of Sepsis Prevalence and Outcomes in Adult Patients in the ICU in India: A Cross-sectional Study

Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia

Long-term costs and cost-effectiveness of adjunctive corticosteroids for patients with septic shock in New Zealand

Outcomes following severe septic shock in a cohort of Aboriginal and Torres Strait Islander people: a nested cohort study from the ADRENAL trial

Challenges in operationalising clinical trials in India during the COVID-19 pandemic

Infection control in the intensive care unit: expert consensus statements for SARS-CoV-2 using a Delphi method

Geographical Representation of Low-and Middle-Income Countries in Randomized Clinical Trials for COVID-19

Balanced Crystalloids versus Saline in Critically Ill Adults — A Systematic Review with Meta-Analysis

Lymphopenia in sepsis—an acquired immunodeficiency?

Impact of 1-hour and 3-hour sepsis time bundles on patient outcomes and antimicrobial use: A before and after cohort study

Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial

Heterogeneity of treatment effect of higher dose dexamethasone by geographic region in patients with COVID-19 and severe hypoxemia - Apost hocevaluation of the COVID STEROID 2 trial

A Comparison of the Commonly Used Surrogate Markers for Citrate Accumulation and Toxicity during Continuous Renal Replacement Therapy with Regional Citrate Anticoagulation.

Selective Decontamination of the Digestive Tract in Invasively Ventilated Patients in an Intensive Care Unit: A protocol for a Systematic Review and Meta-Analysis

ASCOT ADAPT study of COVID-19 therapeutics in hospitalised patients: an international multicentre adaptive platform trial

Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials

Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive without Life Support in Adults with COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial

Sodium chloride or Plasmalyte-148 evaluation in severe diabetic ketoacidosis (SCOPE-DKA): a cluster, crossover, randomized, controlled trial

Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia: The COVID STEROID randomised, placebo-controlled trial

The George Institute for Global Health

The George Institute country sites:

Acknowledgement of Country